Public Health

Statins may not help lower COVID-19 severity or death, study finds

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions...

Lowering this stuff in your blood could lower risk of COVID-19

Keeping blood insulin levels within strict, healthy parameters is a daily goal for people with diabetes. But in a new study from Osaka University, researchers...

Do you need a booster after getting COVID-19?

If you've had COVID-19 and you received two doses of the Pfizer-BioNTech vaccine, should you still get a booster if you are eligible? The answer...

COVID Vaccines can effectively prevent death caused by Delta

In a new study from the Universities of Edinburgh and Strathclyde, researchers found vaccination is over 90% effective at preventing deaths from the Delta...

Long COVID linked to more bacteria in your mouth

In a new study from UMass Chan Medical School, researchers found that patients with persistent long COVID symptoms have oral microbiomes with a much...

What does it mean to be ‘immunocompromised?’

Throughout the COVID-19 pandemic, there have been countless news reports identifying one group of individuals as being particularly vulnerable to the virus: the immunocompromised. We...

This study shows a new way to prevent many COVID-19 variants

The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019. Many of the...

5 ways to keep vaccine cold storage equipment safe from hackers

Electronics in the “cold chain” that health systems use to keep items like COVID-19 vaccines ultra-cold during storage and transport are surprisingly vulnerable to...

COVID-19 is a seasonal infection, study shows

In a new study from the Barcelona Institute for Global Health, researchers found robust evidence that COVID-19 is a seasonal infection linked to low...

What you should know about the COVID-19 pill

A pill to treat COVID-19 is in the works—and it could be a game-changer. It's called molnupiravir, and it's made by Merck and Ridgeback...